Clinical and microbiological analysis of periodontally diseased sites after renal transplant

Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry

Volumn 22, Issue 3, 2002, Pages 115-120

  Vieira, Mara L S O ^a   Martins, Walter ^a   Grisi, Marcio F M ^b   Novaes, Arthur B ^b   Souza, Sergio L S ^b   Salvador, Sérgio L ^b  

^a University of RibeiraTo Preto   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; DIAGNOSTIC AGENT; IMMUNOSUPPRESSIVE AGENT; N BENZOYLARGININE 2 NAPHTHYLAMIDE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BACTEROIDES; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; CLASSIFICATION; COLORIMETRY; COMPARATIVE STUDY; FEMALE; GINGIVA BLEEDING; GINGIVA HYPERPLASIA; HUMAN; ISOLATION AND PURIFICATION; KIDNEY TRANSPLANTATION; MALE; MICROBIOLOGY; MIDDLE AGED; PERIODONTAL DISEASE; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; TOOTH PLAQUE; TREPONEMA;

ADRENAL CORTEX HORMONES; ADULT; ANALYSIS OF VARIANCE; AZATHIOPRINE; BACTEROIDES; BENZOYLARGININE-2-NAPHTHYLAMIDE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COLORIMETRY; CYCLOSPORINE; DENTAL PLAQUE; FEMALE; GINGIVAL HEMORRHAGE; GINGIVAL HYPERPLASIA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PERIODONTAL DISEASES; PERIODONTAL POCKET; PORPHYROMONAS GINGIVALIS; TREPONEMA;

EID: 0036581722     PISSN: 02751879     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1754-4505.2002.tb01173.x     Document Type: Article

References (40)

1. 1 Ward HJ. Allograft rejection. In: Massry SG, Glassock RJ, eds., Textbook of Nephrology, vol. 2. Baltimore: Williams & Wilkins, pp 1485–9, 1989.
2. 2 Storm TB. The immunosuppressive agents in renal transplantation. Kidney Inter 26: 353–65, 1984.
3. 3 Evans RW, Manninen DL, Dong FB, et al. Immunosuppressive therapy as a determinant of transplantation outcomes. Transplantation 55: 1296–305, 1993.
4. 4 Schuller PD, Freedman HL, Lewis DW. Periodontal status of renal transplant patients receiving immunosuppressive therapy. J Periodontol 44: 167–70, 1973.
5. 5 Kardachi BJR, Newcomb GM. A clinical study of gingival inflammation in renal transplants recipients taking immunosuppressive drugs. J Periodontol 49: 307–9, 1978.
6. 6 Been V., Engel D. The effects of immunosuppressive drugs on periodontal inflammation in human renal allografts patients. J Periodontol 53: 245–8, 1982.
7. 7 Tollefsen T., Koppang HS, Messelt E. Immunosuppression and periodontal disease in man: histological and ultrastructural observation. J Periodont Res 17: 329–44, 1982.
8. 8 Yamalik N., Delilbast L., Gulay H., et al. The histologic investigation of gingiva from patients with chronic renal failure, renal transplants and periodontitis: a light and electron microscopic study. J Periodontol 62: 737–44, 1991.
9. 9 Rahman MM, Caglayan F., Rahman B. Periodontal health parame‐parameters in patients with chronic renal failure and renal transplants receiving immunosuppressive therapy. J Nihon Univ Sch Dent 34: 265–72, 1992.
10. 10 Oshrain HI, Mender S., Mandel ID. Periodontal status of patients with reduced immunocapacity. J Periodontol 50: 185–8, 1979.
11. 11 Oshrain HI, Telsey B., Mandel ID. A longitudinal study of periodontal disease in patients with reduced immunocapacity. J Periodontol 54: 151–4, 1983.
12. 12 Hemmerle J., Frank RM. Bacterial invasion of periodontal tissues after experimental immunosuppression in rats. J Biologique Bucale 19: 271–82, 1991.
13. 13 Hemmerle J., Frank RM. Short‐term effect of cyclosporin injections on experimental gingival inflammation in the rat. J Periodontol 64: 24–8, 1993.
14. 14 Fischer RG, Klinge B., Attström R. The effect of cyclosporin‐A on the oral microflora at gingival sulcus of the ferret. J Clin Periodontol 23: 853–60, 1996.
15. 15 Rateitschak‐Plus EM, Hefti A., Lortscher R., Thiel G. Initial observation that cyclosporine A induces gingival enlargement in man. J Clin Periodontol 10: 237–46, 1983.
16. 16 Daley TD, Wysocki GP. Cyclosporin therapy: its significance to the periodontist. J Periodontol 25: 708–12, 1984.
17. 17 Seymour RA, Jacobs DJ. Cyclosporin and the gingival tissues. J Clin Periodontol 19: 1–11, 1992.
18. 18 Seymour RA, Thomason JM, Ellis JS. The pathogenesis of drug‐induced gingival overgrowth. J Clin Periodontol 23: 165–75, 1996.
19. 19 Somacarrera ML, Hernandez G., Acero J., Moscow BS. Factors related to the incidence and severity of cyclosporin‐induced gingival overgrowth in transplant patients: a longitudinal study. J Periodontol 65: 671–5, 1994.
20. 20 Loesche WJ. Rationale for the use of antimicrobial agents in periodontal disease. Int J Technol Assess Health Care 6: 403–17, 1990.
21. 21 Loesche WJ. The antimicrobial treatment of periodontal disease: changing the treatment paradigm. Crit Rev Oral Biol Med 10: 245–75, 1999.
22. 22 Loesche WJ. Bacterial mediators in periodontal disease. Clin Infect Dis 16 (spl.4): 203–10, 1993.
23. 23 Keyes PH, Wright WE, Howard S. The use of the phase contrast microscopy and chemotherapy in the diagnosis and treatment of periodontal lesions–initial report. Quintessence Int Rep 15: 90–2, 1978.
24. 24 Listgarten MA, Helldén L. Relative distribution of bacteria at clinically healthy and periodontally diseased sites in human. J Clin Periodontol 5: 115–32, 1978.
25. 25 Loesche WJ, Lopatin DE, Giordano J., Alcoforado G., Hujoel P. Comparison of the Benzoyl‐DL‐Arginine‐Naphthylamide (BANA) Test, DNA probes and immunological reagents for ability to detect anaerobic periodontal infection due to Porphyromonas gingivalis, Treponema denticola and Bacteroides forsythus. J Clin Microbiol 30: 427–33, 1992.
26. 26 Loesche WJ, Kazor CE, Taylor GW. The optimization of the BANA test as a screening instrument for gingivitis among subjects seeking treatment. J Clin Periodontol 24: 718–26, 1997.
27. 27 Loesche WJ, Bretz WA, Kerchensteiner D., et al. Development of a diagnostic test for anaerobic periodontal infections based on plaque hydrolysis of Benzoyl‐DL‐Arginine‐Naphthylamide. J Clin Microbiol 28: 1551–9, 1990.
28. 28 Grossi SG, Zambon JJ, Ho AW, et al. Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol 65: 260–7, 1994.
29. 29 Ashimoto A., Chen C., Bakker I., Slots J. Polymerase chain reaction detection of 8 putative periodontal pathogens in subgingival plaque of gingivitis and advanced periodontal lesions. Oral Microbiol Immunol 11: 266–73, 1996.
30. 30 Socransky SS, Hafajee AD, Cugini Ma Smith CM, Kent Jr RL. Microbial complexes in subgingival plaque. J Clin Periodontol 25: 134–44, 1998.
31. 31 Papapanou PN, Baelum V., Luan WM, et al. Subgingival microbiota in adult Chinese: prevalence and relation to periodontal disease progression. J Periodontol 68: 651–66, 1997.
32. 32 Figueiredo LC, Toledo BEC, Salvador, SL. The relationship between place BANA reactivity and clinical parameters in subjects with mental disabilities. Special Care Dentist 20: 195–8, 2000.
33. 33 Salvador SL, Grisi MFM, Romanelli RG, et al. Similarities of periodontal clinical and microbiological parameters in mother‐child pairs. Braz Dent J 8: 99–104, 1997.
34. 34 Grisi MFM, Novaes AB, Ito IY, Salvador SL. Relationship between clinical probing depth and reactivity to the BANA test of samples of subgingival microbiota from patients with periodontitis. Braz Dent J 9: 77–84, 1998.
35. 35 Grisi MFM, Salvador SL, Martins Jr. W., Catandi N., Silva‐Netto CR. Correlationship between the CPITN score and anaerobic periodontal infection assessed by BANA Test Assay. Braz Dent J 10: 93–7, 1999.
36. 36 Hafajee AD, Cugini MA, Taner A., et al. Subgingival microbita in healthy, well‐maintained elder and periodontitis subjects. J Clin Periodontol 25: 346–53, 1998.
37. 37 LoFrisco C., Bramson JB. Periodontal screening and recording: perceptions and effects on practice. J Am Dent Assoc 124: 223–6, 1993.
38. 38 Page RC. The role of inflammatory mediators in the pathogenes of periodontal disease. J Periodont Res 26: 230–42, 1991.
39. 39 Savage NM, Seymour GJ, Robinson MF. Cyclosporin‐A‐induced gingival enlarement: a case report. J Periodontol 58: 475–80, 1987.
40. 40 Myrillas TT, Linden GJ, Marley JJ, Irwin CR. Cyclosporin A regulates Interleukin‐lb and Interleukin‐6 expression in gingiva: implications for gingival overgrowth J Periodontol 70: 294–300, 1999.